HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marco R Oggioni Selected Research

batimastat (BB 94)

7/2020Combined therapy with ceftriaxone and doxycycline does not improve the outcome of meningococcal meningitis in mice compared to ceftriaxone monotherapy.
12/2014Inhibition of matrix metalloproteinases attenuates brain damage in experimental meningococcal meningitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marco R Oggioni Research Topics

Disease

9Infections
12/2021 - 09/2004
6Pneumonia (Pneumonitis)
10/2021 - 08/2003
3Sepsis (Septicemia)
07/2016 - 12/2004
2Pneumococcal Pneumonia
10/2021 - 09/2006
2Brain Injuries (Brain Injury)
07/2020 - 12/2014
2Pneumococcal Meningitis (Streptococcus pneumoniae Meningitis)
07/2020 - 09/2004
2Meningococcal Meningitis
07/2020 - 12/2014
2Pneumococcal Infections
12/2011 - 07/2003
2Anthrax
06/2003 - 11/2002
1Liver Abscess
12/2021
1COVID-19
06/2020
1Chronic Obstructive Pulmonary Disease (COPD)
01/2020
1Cystic Fibrosis (Mucoviscidosis)
06/2019
1Cross Infection (Nosocomial Infection)
07/2016
1Hemorrhage
12/2014
1Tuberculosis (Tuberculoses)
10/2013
1Fever (Fevers)
07/2009
1Bacterial Pneumonia
05/2009
1Respiratory Tract Infections (Respiratory Tract Infection)
05/2009
1Persistent Infection
07/2005
1Meningitis
09/2004
1Bacterial Meningitis
09/2004
1Neoplasm Metastasis (Metastasis)
08/2003

Drug/Important Bio-Agent (IBA)

3VaccinesIBA
09/2004 - 11/2002
2Carbapenems (Carbapenem Antibiotics)IBA
01/2021 - 06/2019
2batimastat (BB 94)IBA
07/2020 - 12/2014
2Matrix Metalloproteinases (MMPs)IBA
07/2020 - 12/2014
2Anti-Bacterial Agents (Antibiotics)IBA
01/2020 - 09/2004
2Pharmaceutical PreparationsIBA
10/2013 - 07/2005
2Peptides (Polypeptides)IBA
09/2006 - 12/2004
2Metalloproteases (Metalloproteinases)IBA
09/2006 - 08/2003
1Capsules (Microcapsules)IBA
12/2021
1Azithromycin (Zithromax)FDA LinkGeneric
10/2021
1MacrolidesIBA
10/2021
1Ceftriaxone (Ceftriaxon)FDA LinkGeneric
07/2020
1Doxycycline (Periostat)FDA LinkGeneric
07/2020
1Neuroprotective AgentsIBA
07/2020
1Matrix Metalloproteinase InhibitorsIBA
07/2020
1Tetracycline (Achromycin)FDA LinkGeneric
07/2020
1benzoyl L-arginine methyl ester (BAME)IBA
06/2020
1NucleotidesIBA
10/2019
1DNA Restriction-Modification Enzymes (Restriction Modification Systems)IBA
10/2019
1ceftazidime drug combination avibactamIBA
06/2019
1tazobactam drug combination ceftolozaneIBA
06/2019
1Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric
06/2019
1ChlorhexidineIBA
07/2016
1CoagulaseIBA
07/2016
1Biomarkers (Surrogate Marker)IBA
12/2014
1CytokinesIBA
12/2011
1Type V Secretion SystemsIBA
07/2009
1Neuraminidase (Sialidase)IBA
05/2009
1N-Acetylneuraminic Acid (Sialic Acid)IBA
05/2009
1Proteins (Proteins, Gene)FDA Link
09/2006
1Complement System Proteins (Complement)IBA
09/2006
1Streptococcus pneumoniae plY proteinIBA
09/2006
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
08/2003
1Virulence Factors (Pathogenicity Factors)IBA
08/2003
1ZincIBA
08/2003
1Peptide Hydrolases (Proteases)FDA Link
08/2003
1Membrane Proteins (Integral Membrane Proteins)IBA
07/2003
1Immunoglobulin A (IgA)IBA
07/2003

Therapy/Procedure

3Therapeutics
10/2021 - 09/2004
1Baths
07/2016